Pfizer finds Covid vaccine safe and effective for children 12 to 15

Drug firm in partnership with BioNTech to seek US approval after trials found vaccine ‘well-tolerated’ in school-age children

Pfizer plans to seek emergency approval for its Covid vaccine in younger people after a US trial found the jab prevented the disease and was “well-tolerated” in 12- to 15-year-olds.

Related: Germany restricts use of AstraZeneca jab to over-60s

Continue reading...

from The Guardian https://ift.tt/3dlc4rd